Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
May 07, 2024 10:00 ET
|
Dipharma Francis S.r.l
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.
Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA
October 26, 2023 03:59 ET
|
Dipharma Francis S.r.l
MILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
Dipharma expands its Italian R&D Center to increase its analytical services
April 04, 2023 09:15 ET
|
Dipharma Francis S.r.l
The Company strengthens its analytical R&D capabilities,to better support its customers operating in the CDMO and Generics market. MILAN, Italy, April 04, 2023 (GLOBE NEWSWIRE) -- Dipharma...
Dipharma completes second phase of CGMP expansion at its Kalamazoo site
February 10, 2023 10:29 ET
|
Dipharma Francis S.r.l
MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...
Dipharma receives GMP certification from Brazilian ANVISA
December 01, 2022 08:46 ET
|
Dipharma Francis S.R.L
MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...